Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2021 11:00 ET | Source: Precipio, Inc.

Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors

NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of Mr. Richard Sandberg as Chairman of the Board of...
January 28, 2021 09:30 ET | Source: Precipio, Inc.

Precipio Launches COVID-19 Antibody Testing at Point-of-Care

NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...
January 20, 2021 10:00 ET | Source: Precipio, Inc.

Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups

NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
December 10, 2020 10:15 ET | Source: Precipio, Inc.

Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor

NEW HAVEN, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to...
November 11, 2020 09:00 ET | Source: Precipio, Inc.

Precipio Announces Q3-2020 Shareholder Update Call

NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November 19th...
October 06, 2020 10:00 ET | Source: Precipio, Inc.

Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™

NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...
September 22, 2020 10:30 ET | Source: Precipio, Inc.

Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel

NEW HAVEN, Conn., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ AML (Acute Myeloid...
September 04, 2020 09:00 ET | Source: Precipio, Inc.

Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans

NEW HAVEN, Conn., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting a shareholder call to address questions related to the...
August 20, 2020 13:00 ET | Source: Precipio, Inc.

Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™

NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS...
August 07, 2020 09:00 ET | Source: Precipio, Inc.

Precipio Announces Q2-2020 Corporate Update Call For Shareholders

NEW HAVEN, Conn., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2020 corporate update call on Monday, August 17th at...